Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
Blood test could guide lung cancer treatment without invasive biopsies
Disease control OngoingThis study looks at whether a simple blood test (liquid biopsy) can help doctors monitor how well the drug brigatinib is working in people with a specific type of advanced lung cancer (ALK-positive non-small cell lung cancer). About 33 patients who have not had chemotherapy befor…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Blood test may predict lung cancer outcomes before surgery
Knowledge-focused OngoingThis study tracks 100 people with stage IIIA lung cancer who receive treatment before surgery. Researchers check for tumor DNA in the blood after treatment and before surgery to see if its disappearance is linked to longer survival. The goal is to learn if this blood test can hel…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC